Skip to main content


Dr. Bob Prentice

Dr. Bob Prentice passed away in Kingston on June 12 at the age of 84 after suffering complications from a heart attack.

He leaves his wife of 61 years, Gwen, their children, Gwen (Pierre), Greg, and Laura, and their grandchildren, Thomas and Laina. He is predeceased by their oldest son, Bob.

After graduating in Queen's Meds '60, Bob worked as a pathologist at the Hotel Dieu Hospital.  Dr. Prentice retired from the Department (HDH site) in 1992.



Path120 Term Adjunct

The Department of Pathology and Molecular Medicine in the Queen’s University Faculty of Health Sciences is
recruiting to a Term Adjunct appointment to coordinate and teach PATH120.

Click here for more information

TA Opportunities Fall 2021 & Winter 2022

Graduate Students in Pathology are invited to apply for Teaching Assistantships for several undergraduate course for the 2021-2022 academic year.

For more information:


Funding new frontiers in research

Six research projects at Queen’s have received funding from the New Frontiers in Research Fund’s (NFRF) 2020 Exploration competition, a program that encourages scholars to take risks, and that fosters discoveries and innovations that could have significant impacts on our world.

Tumours that arise throughout the body called neuroendocrine neoplasms (NENs) cause metastatic disease in up to 50 per cent of patients, giving those diagnosed months to years to survive. However, the molecular basis of highly variable clinical outcomes is poorly understood. Neil Renwick (Pathology and Molecular Medicine), Kathrin Tyryshkin (School of Computing) and collaborators have proposed a radical new way to investigate NENs. The researchers propose using graph neural network models, typically used in computer science, to investigate the gene networks that drive or mediate tumor aggressiveness. The understanding of these molecular social networks may improve accurate knowledge of tumour behaviour and even treatment response, improving NEN clinical outcomes.

Queen’s researchers will receive $1.5 million ($250,000 per project) from the fund to advance interdisciplinary projects with multiple partners and collaborators. Nationally, the NFRF competition will provide $14.5 million in grants to researchers across Canada, funding 117 projects.

Pharmaceuticals have become contaminants of emerging concern through increased presence in the environment through wastewater, causing great risk to ecosystems and human health. A contributor to this issue is wastewater treatment facilities that are unable to eliminate pharmaceutical ingredients and excreted drug metabolites through their operating systems. Bas Vriens (Geological Sciences and Geological Engineering) and Martin Petkovich (Biomedical and Molecular Sciences) aim to develop new technology that will act as a 'mega-liver', filtering out harmful pharmaceuticals in wastewater treatment facilities in a cost-efficient way to help ensure good health for our communities and environment.